Overview

Daratumumab and Pomalidomide in Previously Treated Patients With AL Amyloidosis

Status:
Recruiting
Trial end date:
2024-03-31
Target enrollment:
Participant gender:
Summary
This study aims at establishing a new powerful combination of daratumumab and pomalidomide as rescue treatment for patients with R/R AL amyloidosis.
Phase:
Phase 2
Details
Lead Sponsor:
IRCCS Policlinico S. Matteo
Treatments:
Daratumumab
Pomalidomide